128 related articles for article (PubMed ID: 12538747)
1. Bioartificial kidney ameliorates gram-negative bacteria-induced septic shock in uremic animals.
Fissell WH; Lou L; Abrishami S; Buffington DA; Humes HD
J Am Soc Nephrol; 2003 Feb; 14(2):454-61. PubMed ID: 12538747
[TBL] [Abstract][Full Text] [Related]
2. Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock.
Humes HD; Buffington DA; Lou L; Abrishami S; Wang M; Xia J; Fissell WH
Crit Care Med; 2003 Oct; 31(10):2421-8. PubMed ID: 14530746
[TBL] [Abstract][Full Text] [Related]
3. Bioartificial kidney alters cytokine response and hemodynamics in endotoxin-challenged uremic animals.
Fissell WH; Dyke DB; Weitzel WF; Buffington DA; Westover AJ; MacKay SM; Gutierrez JM; Humes HD
Blood Purif; 2002; 20(1):55-60. PubMed ID: 11803160
[TBL] [Abstract][Full Text] [Related]
4. Improvement of cytokine response and survival time by bioartificial kidney therapy in acute uremic pigs with multi-organ dysfunction.
Wang H; Zhang M; Wang X; Mao H; Ying X; Zhu W; Sun C; Jiang C
Int J Artif Organs; 2010 Aug; 33(8):526-34. PubMed ID: 20872347
[TBL] [Abstract][Full Text] [Related]
5. The bioartificial kidney in the treatment of acute renal failure.
Humes HD; Fissell WH; Weitzel WF
Kidney Int Suppl; 2002 May; (80):121-5. PubMed ID: 11982826
[TBL] [Abstract][Full Text] [Related]
6. Metabolic replacement of kidney function in uremic animals with a bioartificial kidney containing human cells.
Humes HD; Fissell WH; Weitzel WF; Buffington DA; Westover AJ; MacKay SM; Gutierrez JM
Am J Kidney Dis; 2002 May; 39(5):1078-87. PubMed ID: 11979353
[TBL] [Abstract][Full Text] [Related]
7. Renal cell therapy is associated with dynamic and individualized responses in patients with acute renal failure.
Humes HD; Weitzel WF; Bartlett RH; Swaniker FC; Paganini EP
Blood Purif; 2003; 21(1):64-71. PubMed ID: 12566664
[TBL] [Abstract][Full Text] [Related]
8. Renal cell therapy in the treatment of patients with acute and chronic renal failure.
Humes HD; Weitzel WF; Fissell WH
Blood Purif; 2004; 22(1):60-72. PubMed ID: 14732813
[TBL] [Abstract][Full Text] [Related]
9. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure.
Humes HD; Weitzel WF; Bartlett RH; Swaniker FC; Paganini EP; Luderer JR; Sobota J
Kidney Int; 2004 Oct; 66(4):1578-88. PubMed ID: 15458454
[TBL] [Abstract][Full Text] [Related]
10. Tissue engineering of a bioartificial renal tubule assist device: in vitro transport and metabolic characteristics.
Humes HD; MacKay SM; Funke AJ; Buffington DA
Kidney Int; 1999 Jun; 55(6):2502-14. PubMed ID: 10354300
[TBL] [Abstract][Full Text] [Related]
11. A bio-artificial renal epithelial cell system conveys survival advantage in a porcine model of septic shock.
Westover AJ; Buffington DA; Johnston KA; Smith PL; Pino CJ; Humes HD
J Tissue Eng Regen Med; 2017 Mar; 11(3):649-657. PubMed ID: 25424193
[TBL] [Abstract][Full Text] [Related]
12. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.
Natanson C; Eichenholz PW; Danner RL; Eichacker PQ; Hoffman WD; Kuo GC; Banks SM; MacVittie TJ; Parrillo JE
J Exp Med; 1989 Mar; 169(3):823-32. PubMed ID: 2647895
[TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock.
Danner RL; Natanson C; Elin RJ; Hosseini JM; Banks S; MacVittie TJ; Parrillo JE
Chest; 1990 Dec; 98(6):1480-7. PubMed ID: 2245691
[TBL] [Abstract][Full Text] [Related]
14. Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock.
Freeman BD; Yatsiv I; Natanson C; Solomon MA; Quezado ZM; Danner RL; Banks SM; Hoffman WD
J Am Coll Surg; 1995 Mar; 180(3):286-92. PubMed ID: 7874338
[TBL] [Abstract][Full Text] [Related]
15. The bioartificial renal tubule assist device to enhance CRRT in acute renal failure.
Humes HD; MacKay SM; Funke AJ; Buffington DA
Am J Kidney Dis; 1997 Nov; 30(5 Suppl 4):S28-31. PubMed ID: 9372976
[TBL] [Abstract][Full Text] [Related]
16. Research into the development of a wearable bioartificial kidney with a continuous hemofilter and a bioartificial tubule device using tubular epithelial cells.
Saito A
Artif Organs; 2004 Jan; 28(1):58-63. PubMed ID: 14720290
[TBL] [Abstract][Full Text] [Related]
17. The bioartificial kidney in the treatment of acute kidney injury.
Song JH; Humes HD
Curr Drug Targets; 2009 Dec; 10(12):1227-34. PubMed ID: 19715535
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of bioartificial renal tubule device prepared with lifespan-extended human renal proximal tubular epithelial cells.
Saito A; Sawada K; Fujimura S; Suzuki H; Hirukawa T; Tatsumi R; Kanai G; Takahashi H; Miyakogawa T; Sanechika N; Fukagawa M; Kakuta T
Nephrol Dial Transplant; 2012 Aug; 27(8):3091-9. PubMed ID: 22467257
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular and metabolic effects of high-dose insulin in a porcine septic shock model.
Holger JS; Dries DJ; Barringer KW; Peake BJ; Flottemesch TJ; Marini JJ
Acad Emerg Med; 2010 Apr; 17(4):429-35. PubMed ID: 20370783
[TBL] [Abstract][Full Text] [Related]
20. Continuous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNFalpha and IL6 plasma concentrations.
Klouche K; Cavadore P; Portales P; Clot J; Canaud B; Béraud JJ
J Nephrol; 2002; 15(2):150-7. PubMed ID: 12018631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
